STOCK TITAN

Lineage, Inc. (LINE) grants director Michael Turner 4,490 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Turner Michael John reported acquisition or exercise transactions in this Form 4 filing.

Lineage, Inc. disclosed that director Michael John Turner received a grant of 4,490 shares of Common Stock as a stock award with no cash paid per share. After this grant, he directly holds 11,612 shares.

The footnote explains this is a grant of time-based restricted stock units (RSUs), which are contingent rights to receive common shares on a one-for-one basis. These RSUs vest in full on the earlier of June 9, 2027, or the date of the next annual meeting of stockholders following June 9, 2026, if he continues to serve the company through that date.

Positive

  • None.

Negative

  • None.
Insider Turner Michael John
Role null
Type Security Shares Price Value
Grant/Award Common Stock 4,490 $0.00 --
Holdings After Transaction: Common Stock — 11,612 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 4,490 shares Time-based RSU award to director Michael John Turner
Price per share $0.00 per share Reported grant price for Common Stock award
Shares after grant 11,612 shares Total Common Stock directly held after the transaction
Vesting date latest June 9, 2027 Latest possible full vesting date for the RSUs
Alternative vesting trigger Next annual meeting after June 9, 2026 Earlier vesting trigger if meeting occurs before June 9, 2027
restricted stock units financial
"Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
contingent rights financial
"RSUs, which are contingent rights to receive shares of common stock on a one-for-one basis"
time-based financial
"Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights"
annual meeting of the Company's stockholders financial
"the date of the next annual meeting of the Company's stockholders following June 9, 2026"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Turner Michael John

(Last)(First)(Middle)
C/O LINEAGE, INC.
46500 HUMBOLDT DRIVE

(Street)
NOVI MICHIGAN 48377

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lineage, Inc. [ LINE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/09/2026A4,490A$0(1)11,612D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock on a one-for-one basis and which vest in full on the earlier to occur of (i) June 9, 2027, and (ii) the date of the next annual meeting of the Company's stockholders following June 9, 2026, subject to continued service with the Issuer through such applicable date.
Remarks:
/s/ Brian Golper, as Attorney-in-Fact for Michael John Turner06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Lineage, Inc. (LINE) director Michael John Turner receive in this Form 4?

Director Michael John Turner received a grant of 4,490 restricted stock units in Lineage, Inc. These RSUs are a stock-based compensation award and give him the right to receive common shares on a one-for-one basis if vesting conditions are met.

How many Lineage, Inc. shares does Michael John Turner hold after this RSU grant?

After the RSU-related stock award, Michael John Turner directly holds 11,612 shares of Lineage, Inc. common stock. This total reflects his position immediately following the reported grant, giving a snapshot of his current direct equity stake in the company.

What are the vesting terms of Michael John Turner’s RSUs at Lineage, Inc. (LINE)?

The RSUs vest in full on the earlier of June 9, 2027, or the date of the next annual stockholder meeting after June 9, 2026. Vesting requires Michael John Turner to continue serving Lineage, Inc. through the applicable vesting date under the award terms.

Is Michael John Turner’s Lineage, Inc. RSU grant a cash transaction?

No, the RSU grant is not a cash transaction; the reported price per share is $0.00. It is a stock-based compensation award that provides contingent rights to receive common stock rather than an open-market purchase involving cash outlay.

How is the size of Michael John Turner’s RSU grant at Lineage, Inc. described?

The award consists of 4,490 restricted stock units tied to Lineage, Inc. common stock. Each RSU represents a contingent right to one share, making the potential share delivery equal to the full 4,490 units upon vesting.